-
-
-
-
-
-
-
CareDx (CDNA) Tops Q1 EPS by 40c, provides guidance
-
-
-
-
-
-
-
CareDx partners with 10x Genomics on transplant rejection research program
-
-
-
-
-
-
-
CareDx submits comment on Medicare coverage policy for transplant testing
-
-
-
-
-
-
-
CareDx (CDNA) Announces Repurchase of 5% of Outstanding Shares
-
-
-
-
-
-
-
Form SCHEDULE 13G/A CareDx, Inc. Filed by: ARK Investment Management LLC
-
-
-
-
-
-
-
H.C. Wainwright Reiterates Neutral Rating on CareDx, Inc (CDNA)
-
-
-
-
-
-
-
CareDx (CDNA) on watch on positive chatter
-
426,541 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

